CBD News‎ > ‎

Cannabidiol NEWS

posted Aug 7, 2015, 4:18 AM by Scott Salisbury

Daily update  August 7, 2015
KannaLife Sciences Announces Publication of Its Global PCT Patent CoveringCannabidiol-like ...
Cannabidiol (CBD) has potential in treating oxidative stress but has limitations in terms of safety and pharmacokinetics, making the safe delivery of an ...
Google PlusFacebookTwitterFlag as irrelevant
BRIEF-GW Pharma says got FDA fast track for intravenous cannabidiol
Receives FDA fast track and EMA orphan designations for intravenous cannabidiol in treatment of neonatal hypoxic-ischemic encephalopathy.
Google PlusFacebookTwitterFlag as irrelevant
GW Pharmaceuticals Receives FDA Fast Track and EMA Orphan Designations for Intravenous ...
GW is advancing an orphan drug program in the field of childhood epilepsy with a focus on Epidiolex® (CBD orcannabidiol), which is in Phase 3 ...
Google PlusFacebookTwitterFlag as irrelevant